Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]

The Canadian Musculoskeletal Conference 2023 is designed for family physicians, bone health specialists, as well as allied health professionals interested in bone health. The conference offers an advanced medical education […]

There are several risk factors for osteoporosis and osteoporotic fractures including age, sex, fragility fracture after the age of 40, use of glucocorticoid drugs, medications, medical conditions that inhibit absorption […]

Facts & Stats Learn more about osteoporosis and related fractures Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue which can lead to increased risk […]

Our Senior Team Dr. Famida Jiwa President and CEO Dr. Jiwa is the President and CEO of Osteoporosis Canada, and has been with the organization since 2006. Prior to joining […]

CMC 2023 The Canadian Musculoskeletal Conference (CMC) hosted by Osteoporosis Canada is November 23 and 24, 2023. Led by national and international experts in osteoporosis, this dynamic conference will offer […]

Medications that can Cause Bone Loss, Falls and/or Fractures A variety of medications can increase bone loss and/or fall risk: Synthetic Glucocorticoids (e.g. Prednisone) Glucocorticoids are produced naturally by the […]

Risk Factors At least 1 in 3 women and 1 in 5 men will break a bone from osteoporosis. Did you know? Fractures from osteoporosis are more common than heart […]

Treatments Did you know? Osteoporosis leads to fragility fractures. These are broken bones that happen from a minor injury but that have major consequences such as pain, disability and sometimes […]